2^nd Global Summit on Hormones and Endocrine Disorders June 27-28, 2016 New Orleans, Louisiana, USA

With enthusiastic support of our Organizing Committee and Editorial Board Member, it’s my pleasure to welcome you to participate in the 2^nd International Conference on Hormones and Endocrine Disorders as a continuum of our previous successful conference, in New Orleans, USA during June 27-28, 2016.

Track 1: Hormones & Steroids

Hormones are chemical messengers that have diverse chemical structures including eicosanoids, steroids, amino acids, peptides, and proteins that are secreted into the blood, which carries them to organs and tissues of the body to exert their functions. They are essential for every activity of life, including the processes of such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Many hormones, such as neurotransmitters, are active in more than one physical process.

Related conference: 

2^nd Hormones and Endocrine Disorders Conference June 27-28, 2016 New Orleans, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15^th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3^rd Congress on Steroid Research, November 15- 18 2015 USA;  40^th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;  20^th annual meeting of the Society for Behavioral Neuroendocrinology, June 22- 25, 2016 Canada; ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 2: Growth Supplements

The body naturally produces growth hormone (HGH or simply GH) in the pituitary gland, and, as its name implies, it is responsible for cell growth and regeneration. Increasing muscle mass and bone density are impossible without GH, but it also plays a major role in maintaining the health of all human tissue, including that of the brain and other vital organs. When secreted, GH remains active in the bloodstream for only a few minutes, but this is enough time for the liver to convert it into growth factors, the most crucial of which is insulin-like growth factor-1, or IGF-1, which boasts a host of anabolic properties. Scientists began to harvest GH from the pituitary glands of cadavers in the 1950s, but didn’t synthesize the first HGH in laboratories until 1981, with its use as a performance-enhancing drug becoming popular shortly thereafter.

Related conference:

 2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28, 2016, USA; 8th Euro Global Diabetes Summit and Medicare Expo  July 14-16, 2016 Birmingham, UK; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; 15^th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE;  2nd Global Conference of the European Society of Contraception and Reproductive Health November 12-16, 2015, Switzerland; American Society for Reproductive Medicine Congress October 17-21, 2015 Baltimore, USA;  22nd IFFS World Congress on Fertility September 21-25, 2016 India; 13th Congress of the European Federation of Sexology (EFS) May 25-28, 2016 CROATIA;  Reproductive Health November 12-16, 2015  Chicago, USA; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 3: Hormones and Infertility 

Infertility is defined as not being able to get pregnant despite having frequent, unprotected sex for at least a year for most people and six months in certain circumstances. Roughly 50% of the women evaluated for infertility progressed to treatment, and only a small proportion were treated with more advanced assisted reproductive technologies such as in vitro fertilization.

Related conference:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Polycystic Ovarian Syndrome Conference November 16-18, 2015, USA;  11^th World Congress of the European Society of Gynecology (ESG), October 21-24 2015 Czech Republic; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada,  Association of Early Pregnancy Units November 3-4 2015  UK, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 4: Hormones in Women Health

Female hormones mainly include estrogen and progesterone. These hormones influences sex differentiation and are responsible for reproduction. These are prescribed by doctors to Women to treat problems such as delayed puberty, pregnancy, Reproduction, Menopause and other medical problems that cause the body to make very low amounts of testosterone. Menopause is characterized as happening 12 months after last menstrual period and imprints the end of menstrual cycles. The move generally has three sections: perimenopause, menopause, and postmenopause. Menopause can happen in your 40s or 50s, yet the normal age is 51 in the United States.

Related conference includes:

2^nd International Conference on  Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; Polycystic Ovarian Syndrome Conference November 16-18, 2015, USA; Pregnancy Summit and Child Health August 29-31, 2016, Brazil; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Reproductive Health November 12-16, 2015  Chicago, USA; 11^th World Congress of the European Society of Gynecology (ESG), October 21-24 2015 Czech Republic; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada,  Association of Early Pregnancy Units November 3-4 2015  UK, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 5 : Body Building Hormones

6 Hormones to control for advanced muscle building results. Muscle growth and fat loss, two key prerequisites to showcasing your stage-ready, beach-worthy body, are, in many respects, contingent upon the optimization of the big two bodybuilding hormones: growth hormone (GH) and testosterone (T)

Related conference:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28, 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE

Track 6:  Cushing's disease

Overproduction of a pituitary gland hormone leads to an overactive adrenal gland. A similar condition called Cushing's syndrome may occur in people, particularly children, who take high doses of corticosteroid medications. It is a cause of Cushing's syndrome characterised by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary (secondary hypercortisolism). This is most often as a result of a pituitary adenoma (specifically pituitary basophilism) or due to excess production of hypothalamus CRH (Corticotropin releasing hormone) (tertiary hypercortisolism/hypercorticism) that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids.

Related conference:

2nd International Conference on Hormones and Endocrine Disorders June 27-28, 2016;  2nd International Conference on Prostate Cancer and Treatment May 5-7 2016, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30 2016, USA; International Conference on Oral, Mouth and Throat Cancer August 18-20 2016, USA; 7^th Global Summit on Cancer Therapy October 05-07 2015 UAE; 4^th International Conference on Blood Malignancies and Treatment April 18-20 2016, UAE, National Cancer Research Institute Cancer Conference, November 1-4 2015 UK; The 2015 San Antonio Breast Cancer Symposium December 8-12, 2015 USA;  10th European Breast Cancer Conference (EBCC-10), March 9-11 2016  Netherlands; World Cancer Congress, October 31 – November 3 2016 France; 17^th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism November 19-22 2016 Albaniap; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 7: Gigantism and Growth Hormone Disorders

Overproduction of growth hormone causes excessive growth. In children, the condition is called gigantism. In adults, it is called acromegaly. Growth hormone stimulates the growth of bones, muscles, and many internal organs. Excessive growth hormone, therefore, leads to abnormally robust growth of all of these tissues. Overproduction of growth hormone is almost always caused by a noncancerous (benign) pituitary tumor (adenoma). Certain rare tumors of the pancreas and lungs also can produce hormones that stimulate the pituitary to produce excessive amounts of growth hormone, with similar consequences.

Related conference:

2nd International conference on Hormones and Endocrine Disorders June 27-28, 2016; 12^th Diabetes Meeting and Therapeutics Expo September 29-October 1, 2016 Canada; 6^th Global Diabetes Summit and Medicare Expo November 02-04, 2015 UAE; 7^th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015 India; 8^th Euro Global Diabetes Summit and Medicare Expo November 03-05, 2015 Spain; 11^th Asia Pacific Diabetes Conference and Expo July 11-13, 2016 Australia; 5^th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension November 5-7 2016, Turkey; 86^th Annual Meeting of the American Thyroid Association September 21-25 2016 Colorado; 3^rd Steroid Research Congress 15-18 Nov 2015 USA; 85^th Annual Meeting of the American Thyroid Association 21–25 September 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 8: Hypothyroidism and Hyperthyroidism

The thyroid gland does not produce enough thyroid hormone, leading to fatigue, constipation, dry skin, and depression. The underactive gland can cause slowed development in children. Some types of hypothyroidism are present at birth. Hypothyroidism can be treated with levothyroxine. The dose is adjusted according to symptoms and normalization of the thyroxine and TSH levels. Thyroid medication is safe in pregnancy. While a certain amount of dietary iodine is important, excessive amounts can worsen certain types of hypothyroidism.

Related conference:                          

2^nd Hormones and Endocrine Disorders Conference June 27-28, 2016 New Orleans, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA; 15^th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3^rd Congress on Steroid Research, November 15- 18 2015 USA;  40^th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;  20^th annual meeting of the Society for Behavioral Neuroendocrinology, June 22- 25, 2016 Canada; ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal;  EndoBridge 15–18 October 2015, Turkey; Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE; Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 9 : Multiple endocrine neoplasia I and II

These are rare, genetic conditions are passed down through families. They cause tumors of the parathyroid, adrenal, and thyroid glands, leading to overproduction of hormones. The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

Related conference:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 10: Polycystic ovary syndrome

Overproduction of androgens interfere with the development of eggs and their release from the female ovaries. PCOS is a leading cause of infertility. Polycystic ovary syndrome is a problem in which a woman hormones are out of balance. It can cause problems with your periods and make it difficult to get pregnant. PCOS also may cause unwanted changes in the way you look. If it isn't treated, over time it can lead to serious health problems, such as diabetes and heart disease. Hormones are chemical messengers that trigger many different processes, including growth and energy production. Often, the job of one hormone is to signal the release of another hormone.

Related conference includes:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 2nd International Conference on Current Trends in Mass Spectrometry May 09-11 2016, USA; 4th International Conference and Exhibition on Biologics and Biosimilars; Asia Pacific Mass Spectrometry Congress October 10-12, 2016 Kuala Lumpur; 2^nd International Conference and Expo on Bio pharmaceutics September 01-03, 2016 Brazil; 3^rd Congress on Steroid Research, November 15- 18 2015 USA;  40^th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France; EndoBridge 15–18 October 2015, Turkey; 11^th Asia Pacific Diabetes Conference and Expo July 11-13, 2016 Australia; 5^th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension November 5-7 2016, Turkey; 86^th Annual Meeting of the American Thyroid Association September 21-25 2016Colorado; 85^th Annual Meeting of the American Thyroid Association 21–25 September 2016, USA; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 11: Steroids and Cancer 

Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems. There are more than 100 different types of cancer. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012. The top three, lung, prostate and colorectal cancers, contributed nearly 42% of all cancers (excluding non-melanoma skin cancer).Approximately 2% to 3% of women in the United States will develop cancer of the endometrium at some point during their lives.

Related conference:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 12: Steroids in Sports

Drugs commonly referred to as steroids can be classified as anabolic (anabolic-androgenic) steroids or corticosteroids. Corticosteroids, such as cortisone or prednisone are drugs that doctors often prescribe to help control inflammation in the body. Corticosteroids are not the same as the anabolic steroids that are often linked with illegal use in sports. Non-medical use of anabolic steroids is illegal and banned by most major sports organizations. In January 2005, the Anabolic Steroid Control Act was amended with the Controlled Substance Act that added anabolic steroids and prohormones (a precursor to a hormone) to the list of controlled substances and makes possession of the substances a federal crime.

Related conference:                

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 13 : Corticosteroids

Corticosteroids, often known as steroids, are an anti-inflammatory medicine prescribed for a wide range of conditions. They're a man-made version of hormones normally produced by the adrenal glands (two small glands that sit on top of the kidneys). Longterm corticosteroids, hydrocortisone (Cortef) and cortisone, are produced by the outer portion of the adrenal gland known as the cortex (hence the name, corticosteroid). Birth control pills can also affect high blood pressure. Women taking birth control pills usually experience a small rise in systolic and diastolic blood pressures.

Systemic corticosteroids refer to corticosteroids that are given orally or by injection and distribute throughout the body. It does not include corticosteroids used in the eyes, ears, or nose, on the skin or that are inhaled, although small amounts of these corticosteroids can be absorbed into the body. Corticosteroids treatment is mainly used to reduce inflammation and suppress the immune system

Related conference:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 14: Anabolic Steroids and Supplements

Anabolic steroids are synthetic (man-made) substances similar to male sex hormone, testosterone. The term “anabolic” means “growth”. Here, it refers to growth in muscle mass. Natural Steroids are performance enhancing substances which cause an increase in anabolic muscle mass and physical strength. Some common examples of anabolic steroids include Androstenedione, Dehydrochloromethyltestosterone (Turinabol), Methandienone (Dianabol), Methyltestosterone (Android), Nandrolone (Durabolin), Oxandrolone (Oxandrin), Oxymetholone (Anadrol), Stanozolol (Winstrol).

Anabolic steroids stimulate growth in tissues, especially bone and muscles. They also increase the production of RBCs (Red blood Cells). Anabolic steroids can be taken orally, are injectable or are used externally. Anabolic steroids are used in the treatment of many medical issues such as delayed puberty in boys, sexual dysfunction in men, breast cancer in women, weight loss in HIV, osteoporosis, anemia, endometriosis and other conditions involving hormonal imbalance.

Related conference includes:

2^nd International Conference on Hormones and Endocrine Disorders Conference June 27-28 2016, USA; 3^rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Metabolic Syndromes October 20-22 2016, UAE; Pregnancy Summit and Child Health August 29-31 2016 Brazil; 4th International Conference on Weight Loss and Fitness Expo November 21-23, 2016 Dubai, UAE;  ESE Basic Course on Endocrine and Neuroendocrine Cancer, February 17-19 2016 Portugal; EndoBridge 15–18 October 2015, Turkey; 7^th ESE Clinical Update, January 15-16 2016 UAE; Reproductive Health November 12-16, 2015  Chicago, USA; XX1 World Congress of Gynecology and Obstetrics October 4-9 2015 Canada; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE